Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Other Income/Expenses (Net)

-$1.26B

TTM · Period ending: · USD

TEVA logo

TEVA Other Income/Expenses (Net)

Latest reported-$1.26B
TEVA TTM Other Income/Expenses (Net) (-$48.20M → -$1.26B)
High-resolution chart · PNG

TEVA other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-1,263,000,000
-910,000,000
-919,000,000
-928,000,000
-964,000,000
-952,000,000
-980,000,000
-1,010,000,000
-1,020,000,000
-1,018,000,001
-986,000,002
-983,000,002
-957,000,002
869,999,998
853,999,999
845,999,999
855,999,999
-997,000,000
-1,047,000,000
-1,017,000,001
-754,000,001
-715,000,001
-653,000,001
-385,000,000
-615,000,000
-597,000,000
-590,000,000
-858,000,000
-876,000,000
-906,000,000
-959,000,000
-927,000,000
-957,000,000
-959,000,000
-895,000,000
-1,481,000,000
-1,372,000,000
-1,224,000,000
-1,321,000,000
-614,000,000
-1,165,000,000
-1,110,000,000
-1,007,000,000
-1,007,000,000
-395,000,000
-438,000,000
-318,000,000
-307,000,000
-301,000,000
-1,822,000,000
-1,999,000,000
-2,086,000,000
-3,274,000,000
-1,772,000,000
-1,584,000,000
-2,700,000,000
-1,496,000,000
-1,379,000,000
-1,347,000,000
-132,000,000
-68,000,000
-236,000,000
-225,000,000
-204,000,000
-253,000,000
-166,000,000
-202,000,000
-472,000,000
-357,000,000
-324,000,000
-318,000,000
-25,000,000
-91,000,000
-71,000,000
-42,000,000
-35,200,000
-60,300,000
-108,700,000
-94,800,000
-108,400,000
-73,500,000
-18,000,000
-4,300,000
22,100,000
24,100,000
26,800,000
25,900,000
18,400,000
8,400,000
-2,300,000
-5,000,000
-25,300,000
-31,000,000
-24,400,000
-24,700,000
-17,230,000
-12,430,000
-16,066,000
-18,458,000
15,194,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.